Corrigendum to 'TAZ is indispensable for c-MYC-induced hepatocarcinogenesis' [J Hepatol (2022) 123-134]

Haichuan Wang1, Shanshan Zhang2, Yi Zhang2

  • 1Liver Transplantation Division, Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu, China; Laboratory of Liver Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.

Journal of Hepatology
|December 30, 2021
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos